Every SEC Form 3/4/5 on record for this filer (CIK 1219039) — 36 issuers, 143 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| KARD | Kardigan, Inc. | Director | 2026-06-18 → 2026-06-24 | 3 | — |
| MASS | 908 Devices Inc. | Director | 2020-12-17 → 2026-06-12 | 9 | $6M |
| SPTX | Seaport Therapeutics, Inc. | 10% owner | 2026-04-30 → 2026-05-04 | 2 | — |
| LYEL | Lyell Immunopharma, Inc. | 10% owner | 2021-06-16 → 2026-03-09 | 5 | — |
| TWST | Twist Bioscience Corp | Director | 2018-10-30 → 2026-02-09 | 14 | −$12M |
| MTSR | Metsera, Inc. | Director | 2025-01-30 → 2025-11-14 | 3 | — |
| NMRA | Neumora Therapeutics, Inc. | 10% owner | 2023-09-14 → 2025-10-29 | 10 | — |
| PRME | Prime Medicine, Inc. | 10% owner | 2022-10-19 → 2025-08-01 | 4 | — |
| MAZE | Maze Therapeutics, Inc. | 10% owner | 2025-01-30 → 2025-01-30 | 1 | — |
| RAPP | Rapport Therapeutics, Inc. | 10% owner · lapsed | 2024-06-06 → 2024-06-10 | 2 | — |
| BOLD | Boundless Bio, Inc. | 10% owner · lapsed | 2024-03-27 → 2024-04-04 | 2 | — |
| SANA | Sana Biotechnology, Inc. | 10% owner · lapsed | 2021-02-03 → 2024-02-12 | 3 | — |
| DALS | DA32 Life Science Tech Acquisition Corp. | Director · lapsed | 2021-07-27 → 2023-08-10 | 4 | $16M |
| QTRX | Quanterix Corp | Director · lapsed | 2017-12-06 → 2023-04-04 | 23 | $4M |
| CDAK | Codiak BioSciences, Inc. | 10% owner · lapsed | 2020-10-13 → 2022-09-15 | 3 | $4M |
| VIR | Vir Biotechnology, Inc. | 10% owner · lapsed | 2019-10-10 → 2022-09-07 | 16 | — |
| ERAS | Erasca, Inc. | 10% owner · lapsed | 2021-07-15 → 2021-07-20 | 2 | — |
| BEAM | Beam Therapeutics Inc. | 10% owner · lapsed | 2020-02-05 → 2021-07-02 | 6 | — |
| VERV | Verve Therapeutics, Inc. | 10% owner · lapsed | 2021-06-16 → 2021-06-23 | 2 | — |
| KRTX | Karuna Therapeutics, Inc. | 10% owner · lapsed | 2019-06-27 → 2021-04-15 | 5 | — |
| MTCR | Metacrine, Inc. | 10% owner · lapsed | 2020-09-15 → 2020-09-22 | 2 | — |
| DNI | Denali Therapeutics Inc. | 10% owner · lapsed | 2019-08-12 → 2019-08-12 | 1 | — |
| SYRS | Syros Pharmaceuticals, Inc. | 10% owner · lapsed | 2016-06-29 → 2019-07-17 | 5 | — |
| IOTS | ADESTO TECHNOLOGIES Corp | Director · lapsed | 2015-10-26 → 2019-06-06 | 9 | $2M |
| FIXX | Homology Medicines, Inc. | 10% owner · lapsed | 2018-03-27 → 2019-05-23 | 3 | — |
| SNNA | Sienna Biopharmaceuticals, Inc. | 10% owner · lapsed | 2017-07-26 → 2019-02-26 | 4 | — |
| GOSS | Gossamer Bio, Inc. | 10% owner · lapsed | 2019-02-07 → 2019-02-12 | 2 | — |
| SRRK | Scholar Rock Holding Corp | 10% owner · lapsed | 2018-05-23 → 2018-05-31 | 2 | — |
| UBX | Unity Biotechnology, Inc. | 10% owner · lapsed | 2018-05-03 → 2018-05-07 | 2 | — |
| PULM | Pulmatrix, Inc. | Filer · lapsed | 2018-04-05 → 2018-04-12 | 2 | — |
| DNLI | Denali Therapeutics Inc. | 10% owner · lapsed | 2017-12-07 → 2017-12-12 | 2 | — |
| XCOM | XTERA COMMUNICATIONS, INC. | 10% owner · lapsed | 2015-11-12 → 2016-10-13 | 5 | $2M |
| PI | IMPINJ INC | 10% owner · lapsed | 2016-07-20 → 2016-08-30 | 3 | — |
| PZRX | PHASERX, INC. | 10% owner · lapsed | 2016-05-17 → 2016-05-25 | 3 | — |
| JUNO | Juno Therapeutics, Inc. | 10% owner · lapsed | 2016-03-17 → 2016-03-17 | 1 | — |
| VBIV | VBI VACCINES INC. | 10% owner · lapsed | 2015-08-17 → 2015-08-17 | 2 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
20 of 36 issuers are covered and open a security page; the rest are on file here only.
